Table 1.
Failed neonatal hearing screening: multivariate logistic regression of risk factors
| Failed neonatal hearing screening [% (n failed hearing screening/n with risk factor) | OR | 95% CI | p | |
|---|---|---|---|---|
| All |
11% (788/7056) |
Ref. |
|
|
| Birth weight# |
|
0.91 |
0.88-0.94 |
7.3 × 10-10* |
| No Aminoglycosides, m.1555A>G - |
8.5% (224/2636) |
1.26 |
1.07-1.49 |
0.0058* |
| No Aminoglycosides m.1555A>G + |
0% (0/2) |
|||
| Aminoglycosides m.1555A>G - |
12.7% (561/4408) |
|||
| Aminoglycosides m.1555A>G + |
30% (3/10) |
|||
| Vancomycin treatment |
15.8% (349/2208) |
1.24 |
1.04-1.47 |
0.015 |
| Furosemide treatment |
17.6% (238/1355) |
1.29 |
1.08-1.57 |
0.0066* |
| Cytomegalovirus-infection |
27% (6/22) |
1.80 |
0.69-4.7 |
0.23 |
| Infants with BPD | 18.6% (195/1048) | 1.21 | 0.99-1.49 | 0.067 |
#OR for birth weight is given per 100 g increased weight. Percentage of failed hearing screening for each category is given in Figure 1. *p < 0.007, multivariate logistic regression.